PF-Atlas › Clinical Trials › NCT03984019

Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis

Cardiac condition measurements · Not specified

Registry ID
NCT03984019
Phase
Not specified
Status
Terminated
Drug / intervention
Cardiac condition measurements
Sponsor
The Netherlands Cancer Institute
Start
2021-01-13
Enrollment
10
Locations
3

About this trial

The investigators aim to optimize the radiation treatment of early stage lung cancer patients. Therefore, detailed understanding is needed of the type of toxicity and the location of these toxicities for patients who receive high fraction doses. These have not been measured in these patients before, therefore our primary research question is: is it possible to measure changes in cardiac condition after radiotherapy, with respect to cardiac arrhythmias, fibrosis, hemodynamic function change and pericarditis?

View NCT03984019 on ClinicalTrials.gov →

Explore related

All Cardiac condition measurements trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT03984019 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.